Article: Orchid Obtains $10 Million Credit Facility From Comerica.

Orchid BioSciences, Inc. today announced that it has obtained a $10 million credit facility from Comerica , a leading financial services company. The credit facility is to be used for working capital and is composed of a $10 million revolving line of credit based on accounts receivable.

"We are pleased to establish this banking relationship with Comerica, a respected financial institution that understands the growth opportunities of our genoprofiling services business," said Andrew P. Savadelis, chief financial officer and senior vice president, finance of Orchid. "This credit facility provides Orchid with a cost-effective, flexible resource to help us meet ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!